Volume 1, Issue 3, November 2022

View Volume 1, Issue 3, November 2022

Moving beyond chemotherapy in the management of follicular lymphoma
Hereditary hematologic malignancies: A Canadian perspective
The evolving treatment landscape of higher-risk MDS
Chronic Myeloid Leukemia: Who should get a treatment-free trial and how?
Evolving strategies in T-cell lymphoma

Published: 2022-11-01

Articles

Moving beyond chemotherapy in the management of follicular lymphoma

Robert Kridel, MD, MPH, PhD

8–11
- PDF (en)
- PDF (fr)
Hereditary hematologic malignancies: a Canadian perspective

Amy M. Trottier, MD, FRCPC

13–17
- PDF (en)
- PDF (fr)
The evolving treatment landscape of higher-risk MDS

Mohamed Elemary, MD, MSc, PhD

19–23
- PDF (en)
- PDF (fr)
Chronic Myeloid Leukemia: who should get a treatment-free trial and how?

Sarit Assouline, MDCM, MSc, FRCPC

25–28
- PDF (en)
- PDF (fr)
Evolving strategies in T-cell lymphoma

Anca Prica, MD, MSc, FRCPC

30–34
- PDF (en)
- PDF (fr)